We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

X:TSXTMX Group Ltd. Analysis

Data as of 2026-07-30 - not real-time

CA$51.72

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

TMX Group is trading at CAD 51.72, comfortably above its 20‑day (49.69) and 50‑day (49.65) moving averages and just above the 200‑day SMA (50.37), indicating short‑term momentum while the broader trend remains neutral. Technical signals are supportive: the MACD line sits at 0.70 above its signal (0.37) producing a bullish histogram, and the RSI at 61 % suggests still‑healthy demand despite approaching overbought territory. Volume is on an upward trajectory, reinforcing the price advance. On the fundamentals side, TMX posted a 16.5 % YoY revenue rise to CAD 1.79 bn, with razor‑thin gross margins of 92.7 % and an operating margin of 50 %, translating into a robust profit margin of 29.9 % and free cash flow of CAD 533 m. The forward EPS of CAD 2.68 represents a 40 % upside versus the trailing EPS of CAD 1.91, and the company pays a modest dividend yield of 1.78 % on a 46 % payout ratio, suggesting dividend sustainability. However, the DCF‑derived fair value of CAD 42.9 is well below the current price, and a PE of 27 x outpaces the industry average of 18 x, flagging the stock as overvalued. Recent news highlights a record month of financings on the TSX and TSX‑V, with 31 new issuers, underscoring TMX’s pivotal role in Canadian capital formation and providing a catalyst for revenue growth. Balancing strong cash generation and market‑position advantages against a premium valuation leads to a nuanced outlook: short‑term momentum is intact, medium‑term valuation pressures linger, but long‑term fundamentals remain compelling.
Overall, investors should weigh the bullish technical backdrop and solid earnings profile against the current price premium and modest dividend yield when deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram and price above short‑term SMAs
  • Increasing trading volume supporting momentum
  • RSI nearing overbought levels, suggesting limited upside

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue growth and high operating margins
  • Premium valuation relative to peers (PE 27 vs industry 18)
  • Sustained dividend payout with comfortable cash flow coverage

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic position in Canadian capital formation and expanding listings
  • Low beta and stable cash generation enabling dividend growth
  • Long‑term upside potential if valuation compresses toward DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth16.50%
Profit Margin29.92%
P/E Ratio27.1
ROE11.92%
ROA0.96%
Debt/Equity42.56
P/B Ratio2.9
Op. Cash FlowCA$753.8M
Free Cash FlowCA$533.0M
Industry P/E18.1

Technical Analysis

TrendNeutral
RSI61.4
SupportCA$46.96
ResistanceCA$52.48
MA 20CA$49.69
MA 50CA$49.65
MA 200CA$50.37
MACDBullish
VolumeIncreasing
Fear & Greed Index90.91

Valuation

Fair ValueCA$42.92
Target PriceCA$64.53
Upside/Downside24.77%
GradeOvervalued
TypeGrowth
Dividend Yield1.78%

Risk Assessment

Beta0.40
Volatility25.61%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.